Improved methodology for direct monitoring of large‐scale manufacturing cell culture using Raman spectroscopy data from process development
Biotechnology Progress · 2026-05 · 42 (3)
DOI: 10.1002/btpr.88513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, online erschienen am 13.05.2026. Verfasst von Hadi El Radi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Merck Millipore SAS, Meylan, France. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Cell Culture Techniques. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Process analytical technology (PAT) is a framework that encourages the implementation of analytical tools for real‐time monitoring of critical batch components during the production of pharmaceuticals. In mammalian cell cultures, Raman spectroscopy as a PAT tool has demonstrated its value for accurate in‐line monitoring of various process parameters as well as quality attributes. However, as process development cultures are transferred to manufacturing scales, the small‐scale models are often adjusted either with new calibration data or with transfer learning algorithms. This model adjustment step makes the overall process transfer to manufacturing less straightforward from an analytical standpoint, requiring additional resources and specific data treatment expertise to fine tune the models. In this work, we compare a specific spectra processing approach against existing approaches reported in the literature for processing Raman spectra in the context of scale‐up challenges. The proposed novelty is a preprocessing strategy which computes spectra normalization based on the 3100–3700 cm −1 band. Data generated at 3 L scale were used to monitor a 3000 L bioreactor without model recalibration or transfer learning with equivalent accuracy as a same scale 3 L bioreactor monitoring. While broader validation case would be warranted, these results demonstrate a direct scale‐up model implementation in large scale manufacturing under the studied conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Merck Millipore SAS, Meylan, France.
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Lianyungang, China.
- Chia Tai Tianqing Pharmaceutical Group, Nanjing Shunxin Pharmaceutical Co., Ltd, Nanjing, China.
- Merck Chemicals Co., Ltd, Shanghai, China.
ORCID-Profile: Hadi El Radi, Jiansheng Lu
Zitieren
APA
El Radi, H., Chen, H., Su, X., Hu, W., Zhang, P., Jin, L., Cao, X., Wang, H., & Lu, J. (2026). Improved methodology for direct monitoring of large‐scale manufacturing cell culture using Raman spectroscopy data from process development. Biotechnology Progress, 42(3). https://doi.org/10.1002/btpr.88513
Vancouver
El Radi H, Chen H, Su X, Hu W, Zhang P, Jin L, et al. Improved methodology for direct monitoring of large‐scale manufacturing cell culture using Raman spectroscopy data from process development. Biotechnology Progress. 2026;42(3). doi:10.1002/btpr.88513
BibTeX
@article{ElRadi2026,
author = {El Radi, Hadi and Chen, Hui and Su, Xiande and Hu, Weiwei and Zhang, Peng and Jin, Linfeng and Cao, Xisheng and Wang, Hui and Lu, Jiansheng},
title = {Improved methodology for direct monitoring of large‐scale manufacturing cell culture using Raman spectroscopy data from process development},
journal = {Biotechnology Progress},
year = {2026},
volume = {42},
number = {3},
doi = {10.1002/btpr.88513}
}
EUVIMED